Intermediate term results for iodine 125 brachytherapy for favorable risk prostate cancer

被引：0
|
作者：
Crook, J. M. [1 ]
Yeung, I. [1 ]
Gillan, C. [1 ]
McLean, M. [1 ]
Lockwood, G. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.622
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2216
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [21] Disease control following iodine-125 seed brachytherapy in low risk prostate cancer.
    Morton, G
    Choo, R
    Loblaw, DA
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S51 - S51
  • [22] I-125 brachytherapy in low/intermediate risk prostate cancer according with NCCN and EAU guidelines
    Trigo, M. L.
    Fernandes, P.
    Garcia, S.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1616 - S1617
  • [23] IODINE 125 BRACHYTHERAPY FOR PROSTATE CANCER IN RAVENNA, EVALUATION OF THE QUALITY OF LIFE (QOL)
    del Duca, M.
    Teodorani, N.
    Palazzi, S.
    Ermanno, E.
    Minguzzi, N.
    Biagini, M. C.
    Di Stefano, C.
    Voce, S.
    Mazzotti, G.
    Morelli, M.
    Mascia, M. P.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S217 - S218
  • [24] Deposition of Iodine-125 on Silver Supports of Microsources for Prostate Cancer Brachytherapy
    Shapovalov, V. V.
    Artamonov, S. A.
    Eldashev, N. V.
    Kutin, A. Yu.
    Nerozin, N. A.
    Podsoblyaev, D. A.
    Samsonov, M. D.
    Togaeva, N. R.
    Tkachev, S. V.
    RADIOCHEMISTRY, 2022, 64 (05) : 641 - 644
  • [25] Deposition of Iodine-125 on Silver Supports of Microsources for Prostate Cancer Brachytherapy
    V. V. Shapovalov
    S. A. Artamonov
    N. V. Eldashev
    A. Yu. Kutin
    N. A. Nerozin
    D. A. Podsoblyaev
    M. D. Samsonov
    N. R. Togaeva
    S. V. Tkachev
    Radiochemistry, 2022, 64 : 641 - 644
  • [26] Permanent iodine 125 implant brachytherapy in localized prostate cancer: results of the first 4 years of experience.
    Bladou, F
    Salem, N
    Simonian-Sauve, M
    Rosello, R
    Ternier, F
    Resbeut, M
    Alzieu, C
    Karsenty, G
    Serment, G
    Gravis, G
    Maraninchi, D
    PROGRES EN UROLOGIE, 2004, 14 (03): : 345 - 352
  • [27] Localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy
    da Silva Franca, Carlos Antonio
    Vieira, Sergio L.
    Carvalho, Antonio Carlos P.
    Bernabe, Antonio Jose S.
    Penna, Antonio Belmiro Rodrigues C.
    BRACHYTHERAPY, 2010, 9 (04) : 307 - 312
  • [28] Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer
    Takamoto, Atsushi
    Tanimoto, Ryuta
    Bekku, Kensuke
    Araki, Motoo
    Sadahira, Takuya
    Wada, Koichiro
    Ebara, Shin
    Katayama, Norihisa
    Yanai, Hiroyuki
    Nasu, Yasutomo
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 507 - 512
  • [29] PSA bounce after 125I-brachytherapy for prostate cancer as a favorable prognosticator
    Engeler, Daniel S.
    Schwab, Christoph
    Thoeni, Armin F.
    Hochreiter, Werner
    Prikler, Ladislav
    Suter, Stefan
    Stucki, Patrick
    Schiefer, Johann
    Plasswilm, Ludwig
    Schmid, Hans-Peter
    Putora, Paul Martin
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (10) : 787 - 791
  • [30] Long-term results of MRI-guided partial prostate brachytherapy for favorable-risk prostate cancer: Implications for focal therapy.
    Paul Linh Nguyen
    Chen, Ming-Hui
    Zhang, Yuanye
    Tempany, Clare M.
    Cormack, Robert A.
    Beard, Clair
    Hurwitz, Mark D.
    Suh, W. Warren
    D'Amico, Anthony Victor
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
12345